Expand TSHA Menu
TSHA MENU

TSHA Latest Press Releases

-- August 11, 2026 --

Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 4:00 PM

-- August 7, 2026 --

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:00 AM

-- August 4, 2026 --

Taysha Gene Therapies to Release Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 11 Globe Newswire 4:00 PM

-- August 3, 2026 --

Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome Globe Newswire 8:00 AM

-- June 25, 2026 --

Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting Globe Newswire 4:01 PM

-- June 24, 2026 --

Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants Globe Newswire 10:33 PM
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Globe Newswire 4:01 PM

-- June 22, 2026 --

Taysha Gene Therapies Announces Completion of Dosing in REVEAL Pivotal Trial and Reports Longer-Term Clinical Data from Part A of REVEAL Phase 1/2 Trials Evaluating TSHA-102 for Rett Syndrome Globe Newswire 8:00 AM

-- June 5, 2026 --

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:01 AM

-- May 6, 2026 --

Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 8:00 AM

-- May 1, 2026 --

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- April 29, 2026 --

Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6 Globe Newswire 8:00 AM

-- April 27, 2026 --

Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting Globe Newswire 5:21 PM

-- April 3, 2026 --

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:00 AM

-- March 19, 2026 --

Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes